| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
SRA
|
Homo sapiens
|
GPL11154
|
||||||
| GSM7427924 |
MDA-MB-231 cells, Vector control, DMSO treatment
|
SRA |
|
1 |
|
Hanqiu Zheng | May 25, 2024 | ||
| GSM7427925 |
MDA-MB-231 cells, ARL11 overexpression, DMSO treatment
|
SRA |
|
1 |
|
Hanqiu Zheng | May 25, 2024 | ||
| GSM7427926 |
MDA-MB-231 cells, Vector control, Olaparib treatment
|
SRA |
|
1 |
|
Hanqiu Zheng | May 25, 2024 | ||
| GSM7427927 |
MDA-MB-231 cells, ARL11 overexpression, Olaparib treatment
|
SRA |
|
1 |
|
Hanqiu Zheng | May 25, 2024 | ||
| GSM7474316 |
Patient 1, LN221, Fragmentation
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474317 |
Patient 3, LN221, Fragmentation
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474318 |
Patient 4, LN221, IVA
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474319 |
Patient 5, Matrigel, IVA
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474320 |
Patient 6, Matrigel, IVA
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474321 |
Patient 1, Matrigel, Fragmentation
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474322 |
Patient 2, Matrigel, IVA
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474323 |
Patient 3, Matrigel, Fragmentation
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474324 |
Patient 4, Matrigel, IVA
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474325 |
Patient 5, Fresh
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474326 |
Patient 6, Fresh
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474327 |
Patient 1, Fresh
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474328 |
Patient 2, Fresh
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474329 |
Patient 3, Fresh
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474330 |
Patient 4, Fresh
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 | ||
| GSM7474331 |
Patient 7, Fresh
|
SRA |
|
1 |
|
Tianyi Li | May 24, 2024 |
